InsidersTradesSigma
Explore the complete record of transactions filed by Wolff Stefani, Chief Operating Officer. Insider active across 1 companies, notably Nurix Therapeutics, Inc.. In total, 1 reports have been logged. The latest transaction was filed on 30 April 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
Wolff Stefani is the EVP and COO at Nurix Therapeutics, Inc. She oversees the company's operations, contributing to efficiency and implementation of the strategy.